Marlene Colucci
About Marlene Colucci
Marlene Colucci (age 62) is an independent director of GXO and has served as vice chair since August 2, 2021; she is expected to become Lead Independent Director following the 2025 Annual Meeting. She is CEO of The Business Council (since July 2013), holds a JD from Georgetown University Law Center, and brings two decades of public policy experience (White House Special Assistant for Domestic Policy, U.S. Department of Labor) and senior legal practice at Akin Gump Strauss Hauer & Feld LLP. Director since 2021; independence affirmed by the Board under NYSE standards.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| The White House (Office of Domestic Policy) | Special Assistant to President George W. Bush (labor, transportation, postal reform) | Sep 2003–Jun 2005 | Developed policy and advised President and staff |
| American Hotel & Lodging Association | EVP, Public Policy | Sep 2005–Jun 2013 | Led industry advocacy; labor/transport policy expertise |
| U.S. Department of Labor | Deputy Assistant Secretary, Office of Congressional & Intergovernmental Affairs | Prior to 2003 | Government relations and policy coordination |
| Akin Gump Strauss Hauer & Feld LLP | Senior Counsel | 12+ years | Legal advisory; governance perspective |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| The Business Council | Chief Executive Officer | Jul 2013–present | CEO leadership; governance perspective |
| National Endowment for Democracy | Director | n/a | Nonprofit board; civic governance |
| QXO, Inc. (NYSE: QXO) | Director | Jun 6, 2024–present | Board service alongside QXO leadership |
Board Governance
- Independence: GXO Board affirmatively determined Colucci is independent under NYSE rules; Audit, Compensation, and Nominating committees composed entirely of independent directors.
- Roles and committees: Member, Compensation Committee; Member, Nominating, Corporate Governance and Sustainability Committee. Expected post-2025 Annual Meeting: continues on both; Board established an Operational Excellence Committee (OEC) effective at the meeting (Colucci not listed as OEC member).
- Leadership: Vice Chair role ends at the 2025 Annual Meeting; expected to serve as Lead Independent Director thereafter, presiding over executive sessions and balancing Board leadership.
- Attendance and engagement: Board held 11 meetings in 2024; each current director attended >80% of Board meetings and >90% of committee meetings; all directors attended the 2024 Annual Meeting.
- Shareholder support: 2025 re‑election vote support for Colucci: For 88,037,186; Against 11,283,521; Abstentions 95,557; indicating strong investor confidence.
Fixed Compensation
| Component (2024) | Amount (USD) | Notes |
|---|---|---|
| Annual cash retainer | $80,000 | Paid quarterly in arrears; no meeting fees |
| Vice Chair cash retainer | $25,000 | Additional retainer for vice chair |
| Committee chair fees | $0 | Colucci not a chair in 2024 |
| Equity retainer (Time‑Based RSUs) | $269,294 | Includes Jan 2, 2024 grant ($79,167; 5/12) and May 21, 2024 annual grant ($190,000) methodology |
| Total 2024 director compensation | $374,294 | Cash $105,000 + stock $269,294 |
- Stock ownership guidelines: Non‑employee directors must hold 6× annual cash retainer; 70% net shares retention until met; all directors in compliance as of proxy date.
- No meeting fees; expenses reimbursed; no options granted to directors.
Performance Compensation
- Structure: GXO uses time‑based RSUs for directors; no performance‑based equity (no PSUs or options) or cash performance bonuses for directors; RSUs vest on time schedules.
- Vesting and holdings (Colucci):
- RSUs held (12/31/2024): 4,899 units.
- Unvested RSUs scheduled to vest: 3,617 units vest on May 13, 2025.
| Grant/Status | Date | Units | Fair Value (USD) |
|---|---|---|---|
| RSUs outstanding | 12/31/2024 | 4,899 | n/a |
| RSUs vesting | 05/13/2025 | 3,617 | n/a |
No director performance metrics apply; all director equity grants are time‑based with ownership retention requirements.
Other Directorships & Interlocks
| Company/Org | Type | Role | Dates | Interlocks/Notes |
|---|---|---|---|---|
| QXO, Inc. | Public | Director | Since Jun 6, 2024 | Brad Jacobs is Chairman/CEO at QXO; multiple GXO directors have QXO ties → monitor information flow and potential related perspectives (Board independence maintained via NYSE tests). |
| XPO, Inc. | Public (prior) | Director | Feb 7, 2019–Aug 2, 2021 | Resigned to join GXO Board at spin‑off inception. |
| National Endowment for Democracy | Nonprofit | Director | n/a | Civic governance role; not a commercial conflict. |
- Compensation Committee interlocks: None; committee members (including Colucci) were not company officers; no reciprocal board/comp committee cross‑service by GXO executives at other companies.
Expertise & Qualifications
- Public policy leadership (labor, transportation, postal reform), government experience, and legal expertise (Akin Gump senior counsel).
- Corporate governance, human resources oversight, sustainability oversight via Nominating, Corporate Governance and Sustainability Committee.
- Brings governance and operations perspectives from leading premier CEO association (The Business Council).
Equity Ownership
| Metric | Amount | Notes |
|---|---|---|
| Beneficial ownership (SEC definition) | 22,896 shares | Includes 3,617 unvested RSUs vesting 05/13/2025 |
| Common shares (excluding unvested RSUs) | 19,279 shares | As of Record Date |
| Unvested RSUs | 3,617 units | Vest 05/13/2025 |
| % of shares outstanding | ~0.0196% | 22,896 ÷ 117,063,470 shares outstanding (Record Date) |
- Hedging/pledging: GXO policy prohibits pledging/hedging of company stock without preclearance; insider trading policy and blackout procedures apply to directors.
- Ownership guideline compliance: Directors in compliance as of proxy date; retention requirement in place until guideline met.
Compensation Committee Analysis (context for governance quality)
- 2024 Compensation Committee: Chair Dr. Jason Papastavrou; Members Colucci and Joli Gross; seven meetings plus one unanimous written consent; independent consultant F.W. Cook retained; committee independence affirmed; no conflicts of interest.
- Committee oversight: Pay‑for‑performance philosophy; robust clawback policy; stock ownership/retention; no option repricing; no excise tax gross‑ups; engages with shareholders.
Say‑on‑Pay & Shareholder Feedback
| Metric | 2024 | 2025 |
|---|---|---|
| Advisory vote to approve executive compensation | For 90,567,227; Against 10,065,553; Abstentions 114,005 | For 88,325,841; Against 10,874,029; Abstentions 216,394; Broker non‑votes 8,082,272 |
| Committee view of 2024 vote | 90% approval indicated strong support for program | — |
- 2025 director elections: Colucci re‑elected with 88,037,186 For; 11,283,521 Against; 95,557 Abstentions; strong support despite board refresh.
Related Party Transactions (Conflict Screening)
- GXO disclosed no related‑party transactions >$120,000 since Jan 1, 2024 involving directors, executives, 5% holders, or immediate family members.
- Independence review included analysis of non‑Item 404 relationships; for certain other directors, ordinary‑course transactions noted; no such disclosure for Colucci.
Governance Assessment
-
Strengths:
- Independence and expected elevation to Lead Independent Director enhance counterbalance to Chairman and management.
- High attendance and committee engagement support board effectiveness.
- Director compensation aligned with market: modest cash; majority equity via time‑based RSUs; robust stock ownership policy and retention.
- Strong investor support in director election and say‑on‑pay.
-
Watch items:
- Interlocks with QXO leadership could create perceived alignment risks; monitor for related‑party transactions or undue influence (none disclosed; independence affirmed).
- Transition in board leadership (vice chair role terminated; new OEC committee) warrants monitoring of committee effectiveness and oversight continuity.
-
Red Flags:
- None disclosed regarding related‑party transactions, low attendance, hedging/pledging, or pay anomalies for directors.